MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2018 International Congress

    Using tablet devices to educate patients about dystonia and botulinum toxin for movement disorders

    S. Bobker, A. Hanineva, P. Popa, H. Ellsworth, X. Wu, I. Diaz, N. Hellmers, C. Henchcliffe, H. Sarva (New York, NY, USA)

    Objective: To assess the efficacy of tablet-based learning modules for patient education in an outpatient movement disorders center. Background: Educational materials improve patient understanding, and…
  • 2018 International Congress

    Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

    W. Deeb, W. Hu, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To examine the physiological effects of botulinum toxin (BoNT) therapy, as measured by paired-pulse transcranial magnetic stimulation (TMS), in patients with primary cervical dystonia…
  • 2018 International Congress

    5 Years’ Experience of Ixcellence Network®, an International Innovative Educational Program to improve Cervical Dystonia and Spastic paresis Management Practices

    C. Colosimo, T.M. Chung, L.J. Jacinto, K. Bahtia, T. Landreau, R. Bhidayasiri (Roma, Italy)

    Objective: To describe the impact of the Ixcellence® Network training program on physicians using botulinum neurotoxin-A (BoNT-A) in cervical dystonia (CD) and spastic paresis (SP).…
  • 2018 International Congress

    Combined EMG and endoscopy guided botulinum toxin injection of the longus capitis muscle in cervical dystonia with anterocaput

    J. Michelis, F. Schuler, I. Debove, J. Müllner, L. Lachenmayer, E. Seifert (Bern, Switzerland)

    Objective: To describe a safe and well tolerated technique of botulinum toxin (BnTA) injection into the longus capitis muscle (LCM) in a patient with anterocaput…
  • 2018 International Congress

    First Results from the Ixcellence Network® Survey: Botulinum Neurotoxin-A Usage and Training in Cervical Dystonia & Spastic Paresis

    R. Bhidayasiri, K. Bahtia, L.J. Jacinto, TM. Chung, T. Landreau, C. Colosimo (Bangkok, Thailand)

    Objective: To describe the current situation of training and practices among physicians using botulinum neurotoxin-A (BoNT-A) injections in the treatment of Cervical Dystonia (CD) and…
  • 2018 International Congress

    Usefulness of ultrasound-guided botulinum toxin injections in a case of cervical dystonia

    C. Figueiredo, L. Rebordão, M. Santos, P. Lobo, C. Costa (Amadora, Portugal)

    Objective: Case report of a patient with a severe form of cervical dystonia (CD) Background: Unsuccessful treatment with botulinum toxin of CD may result from…
  • 2018 International Congress

    Hemidystonia due to midbrain hemorrhage: An unusal complication of Deep Brain Stimulation

    G. Sciacca, S. Bonvegna, F. Dematteis, M. Lanotte, A. Romagnolo, L. Lopiano, U. Dimanico, M. Rizzone (Catania, Italy)

    Objective: In this case report, we describe the development of hemidystonia due to hemorrhagic complication after subthalamic deep brain stimulation (STN-DBS) in a patient with…
  • 2018 International Congress

    Impaired reaching movements in idiopathic cervical dystonia patients

    A. Castagna, L. Sciumè, A. Caronni, D. Anastasi, A. Montesano, A. Marzegan (Milano, Italy)

    Objective: Aim of the current study is to describe how patients with idiopathic cervical dystonia (CD) perform reaching movements with their upper limb (i.e. a…
  • 2018 International Congress

    Factors predicting patient satisfaction with botulinum toxin treatment in cervical dystonia patients who have been treated for a year

    V. Misra, C. Colosimo, T. Chung, D. Charles, S. Om, P. Maisonobe (London, United Kingdom)

    Objective: Investigate factors influencing satisfaction with botulinum toxin-A (BoNT-A) treatment in patients with cervical dystonia (CD) who have been treated for 1 year. Background: Little…
  • 2018 International Congress

    Reliability and Feasibility of Telemedicine Evaluation of Cervical Dystonia

    A. Fraint, G. Pal, G. Stebbins, C. Comella (Chicago, IL, USA)

    Objective: Determine reliability and feasibility of telemedicine evaluation of Cervical Dystonia (CD). Background: Many CD patients receiving botulinum toxin (BoNT) injections are not able to…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley